跳至主要内容
临床试验/TCTR20220516006
TCTR20220516006已完成2 期

ong-Term Effects of Allulose Consumption on Glucose Ho-meostasis, Metabolic Parameters, Incretin Levels, and Inflam-matory Markers in Patients with Type 2 Diabetes: A Dou-ble-Blind, Randomized, Controlled Crossover Clinical Trial

the Innovation and Technology Assistance Program (ITAP) of the National Science and Technology Development Agency (NSTDA)0 个研究点目标入组 16 人开始时间: 2022年5月16日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
16

研究概览

简要总结

Twelve weeks allulose consumption resulted in neutral effect on glucose homeostasis, body composition, incretin levels, transient decreased high-density lipoprotein cholesterol level, and increased MCP-1 level.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • 1. diagnosis of T2D
  • 2. being treated with metformin monotherapy or lifestyle modification
  • 3. a glycated hemoglobin (HbA1c) of <8%
  • 4. not having consumed artificial sweetener for at least 2 weeks

排除标准

  • 1. chronic kidney disease (CKD) (estimated glomerular filtration rate [eGFR] <60 ml/min/m2)
  • 2. aminotransferase >3 times the upper limit of normal range
  • 3. severe illness
  • 4. phenylke-tonuria
  • 5. pregnant or breastfeeding
  • 6. taking medication that affects glycemic con-trol (e.g., steroid, estrogen, androgen)

研究者

发起方
the Innovation and Technology Assistance Program (ITAP) of the National Science and Technology Development Agency (NSTDA)

相似试验